Diffuse Venous Malformations of the Upper Extremity (Bockenheimer Disease): Diagnosis and Management.
Adolescent
Adult
Arteriovenous Malformations
/ diagnosis
Combined Modality Therapy
/ methods
Compression Bandages
Cytoreduction Surgical Procedures
/ adverse effects
Disease Progression
Female
Follow-Up Studies
Humans
Male
Middle Aged
Quality of Life
Retrospective Studies
Sclerotherapy
/ adverse effects
Treatment Outcome
Upper Extremity
/ blood supply
Vascular Malformations
/ diagnosis
Veins
/ abnormalities
Young Adult
Journal
Plastic and reconstructive surgery
ISSN: 1529-4242
Titre abrégé: Plast Reconstr Surg
Pays: United States
ID NLM: 1306050
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
entrez:
25
11
2020
pubmed:
26
11
2020
medline:
16
1
2021
Statut:
ppublish
Résumé
Diffuse venous malformations that involve all tissues in the upper limb and ipsilateral chest wall are known as "phlebectasia of Bockenheimer." The authors describe their experience with management of this uncommon vascular anomaly. The authors' Vascular Anomalies Center registry comprised 18,766 patients over a 40-year period. This review identified 2036 patients with venous malformations of the extremities (10.8 percent), of whom only 80 (0.43 percent) had Bockenheimer disease. The authors retrospectively analyzed patient characteristics, diagnostics, treatments, and complications. The venous malformation was first noted at birth or within the first few years of life with slow and gradual progression. Pain was related to engorgement of the limb. Thromboses and phleboliths were common, but diffuse intravascular coagulopathy occurred in only 12 patients (15 percent). Skeletal involvement was demonstrated as lytic lesions, cortical scalloping, osteopenia, and pathologic fractures. Management included compression garments (100 percent), sclerotherapy (27.5 percent), and resection of symptomatic areas in 35 percent of patients. Adjunctive pharmacologic medication was given in 7.5 percent. Following resection, 17 patients (60 percent) had one or more complications: hematoma, wound dehiscence, flap loss, contracture, and psychosis. There were no deaths. Symptoms improved in all patients with useful functional outcomes. The decision to pursue compression, sclerotherapy, pharmacologic treatment, or resection alone or in combination was made by an interdisciplinary team. Although extensive venous malformations cannot be completely ablated, debulking of symptomatic regions, resection of neuromas, and noninvasive treatments improve the quality of life. Despite the bulk and weight of the arm, forearm, and hand, and the ominous appearance on magnetic resonance imaging, these patients remain functional. Therapeutic, V.
Sections du résumé
BACKGROUND
Diffuse venous malformations that involve all tissues in the upper limb and ipsilateral chest wall are known as "phlebectasia of Bockenheimer." The authors describe their experience with management of this uncommon vascular anomaly.
METHODS
The authors' Vascular Anomalies Center registry comprised 18,766 patients over a 40-year period. This review identified 2036 patients with venous malformations of the extremities (10.8 percent), of whom only 80 (0.43 percent) had Bockenheimer disease. The authors retrospectively analyzed patient characteristics, diagnostics, treatments, and complications.
RESULTS
The venous malformation was first noted at birth or within the first few years of life with slow and gradual progression. Pain was related to engorgement of the limb. Thromboses and phleboliths were common, but diffuse intravascular coagulopathy occurred in only 12 patients (15 percent). Skeletal involvement was demonstrated as lytic lesions, cortical scalloping, osteopenia, and pathologic fractures. Management included compression garments (100 percent), sclerotherapy (27.5 percent), and resection of symptomatic areas in 35 percent of patients. Adjunctive pharmacologic medication was given in 7.5 percent. Following resection, 17 patients (60 percent) had one or more complications: hematoma, wound dehiscence, flap loss, contracture, and psychosis. There were no deaths. Symptoms improved in all patients with useful functional outcomes.
CONCLUSIONS
The decision to pursue compression, sclerotherapy, pharmacologic treatment, or resection alone or in combination was made by an interdisciplinary team. Although extensive venous malformations cannot be completely ablated, debulking of symptomatic regions, resection of neuromas, and noninvasive treatments improve the quality of life. Despite the bulk and weight of the arm, forearm, and hand, and the ominous appearance on magnetic resonance imaging, these patients remain functional.
CLINICAL QUESTION/LEVEL OF EVIDENCE
Therapeutic, V.
Identifiants
pubmed: 33234962
doi: 10.1097/PRS.0000000000007365
pii: 00006534-202012000-00018
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1317-1324Références
Bockenheimer P. Uber die genuine diffuse Phlebektasie der oberen Extremitat. Von Rindfleisch Festschrift. 1907; 38:311–338
Kubiena HF, Liang MG, Mulliken JB. Genuine diffuse phlebectasia of Bockenheimer: Dissection of an eponym. Pediatr Dermatol. 2006; 23:294–297
Sonntag E. Ueber genuine diffuse Phlebektasie am Bein. Munch Med Wochenschr. 1919; 66:155–157
Freund D. Diffuse genuine phlebectasia. Arch Surg. 1936; 33:113–121
Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics. Plast Reconstr Surg. 1982; 69:412–422
Eifert S, Villavicencio JL, Kao TC, Taute BM, Rich NM. Prevalence of deep venous anomalies in congenital vascular malformations of venous predominance. J Vasc Surg. 2000; 31:462–471
Upton J, Marler J. Mathes S, Hentz V, eds. Vascular anomalies of the upper extremity. In: Plastic Surgery. 2006, Philadelphia: Saunders; 369–413
Enjolras O, Ciabrini D, Mazoyer E, Laurian C, Herbreteau D. Extensive pure venous malformations in the upper or lower limb: A review of 27 cases. J Am Acad Dermatol. 1997; 36:219–225
Vollmar J, Vogt K. Angiodysplasia and the skeletal system. Chirurg. 1976; 47:205–213
Mattassi R. Differential diagnosis in congenital vascular-bone syndromes. Semin Vasc Surg. 1993; 6:233–244
Weiss T, Mädler U, Oberwittler H, Kahle B, Weiss C, Kübler W. Peripheral vascular malformation (Servelle-Martorell). Circulation. 2000; 101:E82–E83
Lala S, Mulliken JB, Alomari AI, Fishman SJ, Kozakewich HP, Chaudry G. Gorham-Stout disease and generalized lymphatic anomaly: Clinical, radiologic, and histologic differentiation. Skeletal Radiol. 2013; 42:917–924.
Oda FT, McLaughlin JS, Yeager GH, Buxton RW, Mansberger AR Jr. Vascular anomalies of the extremity associated with abnormal growth. Am Surg. 1962; 28:775–783
Mazoyer E, Enjolras O, Laurian C, Houdart E, Drouet L. Coagulation abnormalities associated with extensive venous malformations of the limbs: Differentiation from Kasabach-Merritt syndrome. Clin Lab Haematol. 2002; 24:243–251
Boyd JB, Mulliken JB, Kaban LB, Upton J III, Murray JE. Skeletal changes associated with vascular malformations. Plast Reconstr Surg. 1984; 74:789–797
Enjolras O, Chapot R, Merland JJ. Vascular anomalies and the growth of limbs: A review. J Pediatr Orthop B. 2004; 13:349–357
Servelle M. Klippel and Trénaunay’s syndrome: 768 operated cases. Ann Surg. 1985; 201:365–373
Servelle M, Trinquecoste P. Des angiomes veineux. Arch Mal Coeur Vaiss. 1948; 41:436–442
Servelle M. Les malformations congénitales des veines. Rev Chir. 1949; 87:88–106
Alomari A, Dubois J. Interventional management of vascular malformations. Tech Vasc Interv Radiol. 2011; 14:22–31
Hein KD, Mulliken JB, Kozakewich HP, Upton J, Burrows PE. Venous malformations of skeletal muscle. Plast Reconstr Surg. 2002; 110:1625–1635
Lamba S, Keshava SKN, Moses V, Surendrababu N, Gupta AK. Ethanol sclerotherapy for treatment of venous malformations of face and neck: A single center experience. Eur J Plast Surg. 2012; 35:345–350
Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol. 2004; 15:431–445
Hammer FD, Boon LM, Mathurin P, Vanwijck RR. Ethanol sclerotherapy of venous malformations: Evaluation of systemic ethanol contamination. J Vasc Interv Radiol. 2001; 12:595–600
Lee BB, Kim DI, Huh S, et al. New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation. J Vasc Surg. 2001; 33:764–772
Rimon U, Garniek A, Galili Y, Golan G, Bensaid P, Morag B. Ethanol sclerotherapy of peripheral venous malformations. Eur J Radiol. 2004; 52:283–287
Jin Y, Lin X, Li W, Hu X, Ma G, Wang W. Sclerotherapy after embolization of draining vein: A safe treatment method for venous malformations. J Vasc Surg. 2008; 47:1292–1299
Adams DM, Trenor CC III, Hammill AM, et al. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics. 2016; 137:e20153257
Venot Q, Blanc T, Rabia SH, et al. Targeted therapy in patients with PIK3CA-related overgrowth syndrome. Nature. 2018; 558:540–546
Upton J, Coombs CJ, Mulliken JB, Burrows PE, Pap S. Vascular malformations of the upper limb: A review of 270 patients. J Hand Surg Am. 1999; 24:1019–1035
Upton J, Mulliken JB, Murray JE. Classification and rationale for management of vascular anomalies in the upper extremity. J Hand Surg Am. 1985; 10:970–975
Holly BP, Patel YA, Park J, et al. Preoperative epoxy embolization facilitates the safe and effective resection of venous malformations in the hand and forearm. Hand (N Y). 2017; 12:335–341
Manoli T, Micheel M, Ernemann U, Schaller HE, Stahl S. Treatment algorithm and clinical outcome of venous malformations of the limbs. Dermatol Surg. 2015; 41:1164–1170